📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes (2017)

First Author: Unnikrishnan A

Attributed to: Understanding cell fate decisions in normal and abnormal haematopoiesis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.celrep.2017.06.067

PubMed Identifier: 28723562

Publication URI: http://europepmc.org/abstract/MED/28723562

Type: Journal Article/Review

Parent Publication: Cell Reports

Issue: 3